D-0642-2022 Class II Terminated
FDA drug recall D-0642-2022 was initiated by Preferred Pharmaceuticals, Inc. on Feb 22, 2022 and is designated Class II. Reason for recall: CGMP deviations The recall status is terminated (terminated May 5, 2023). Affected quantity: 276 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Mar 9, 2022
- Initiation Date
- Feb 22, 2022
- Termination Date
- May 5, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 276 bottles
Product Description
Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.
Reason for Recall
CGMP deviations
Distribution Pattern
Nationwide in the USA.
Code Information
Lot #s: a) G2919M, I0619O, F1419J; b) H3019Q; c) F1219N, F1919D, H0219D, I0519R, J0319G, Exp. 03/31/2022.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0642-2022
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026